- Home
- FOR vs AMPH Comparison
FOR vs AMPH Comparison
Compare FOR & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- AMPH
- Stock Information
- Founded
- FOR 2005
- AMPH 1996
- Country
- FOR United States
- AMPH United States
- Employees
- FOR N/A
- AMPH N/A
- Industry
- FOR Real Estate
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- FOR Finance
- AMPH Health Care
- Exchange
- FOR Nasdaq
- AMPH Nasdaq
- Market Cap
- FOR 1.0B
- AMPH 1.1B
- IPO Year
- FOR 2007
- AMPH 2014
- Fundamental
- Price
- FOR $26.01
- AMPH $23.81
- Analyst Decision
- FOR Strong Buy
- AMPH Hold
- Analyst Count
- FOR 4
- AMPH 5
- Target Price
- FOR $30.25
- AMPH $36.25
- AVG Volume (30 Days)
- FOR 227.3K
- AMPH 489.0K
- Earning Date
- FOR 07-22-2025
- AMPH 08-07-2025
- Dividend Yield
- FOR N/A
- AMPH N/A
- EPS Growth
- FOR N/A
- AMPH N/A
- EPS
- FOR 3.19
- AMPH 2.68
- Revenue
- FOR $1,543,300,000.00
- AMPH $722,679,000.00
- Revenue This Year
- FOR $4.28
- AMPH $0.92
- Revenue Next Year
- FOR $7.75
- AMPH $5.55
- P/E Ratio
- FOR $8.16
- AMPH $8.89
- Revenue Growth
- FOR 2.35
- AMPH 1.37
- 52 Week Low
- FOR $18.00
- AMPH $20.39
- 52 Week High
- FOR $34.82
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- FOR 71.59
- AMPH 61.54
- Support Level
- FOR $24.48
- AMPH $20.70
- Resistance Level
- FOR $26.69
- AMPH $22.90
- Average True Range (ATR)
- FOR 0.85
- AMPH 0.81
- MACD
- FOR 0.05
- AMPH 0.23
- Stochastic Oscillator
- FOR 83.77
- AMPH 79.35
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.